Since our proposed model may be applied to data related to different AAs and different categories of patients (ranging from normal glucose tolerance to type 2 diabetes), we are confident that it will contribute to clarify the possible specific effects of various AAs on insulin secretion, also likely depending on the studied population. This evidence concerns the gene INS and type 2 diabetes mellitus.